Marshall Wace, LLP Pa Vmed Inc. Transaction History

Marshall Wace, LLP

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Aug 13, 2021	SELL	$3.95 - $6.88 $605,471 - $1.05 Million	-153,284 Reduced 74.45%	52,593 $337,000
Q1 2021 May 17, 2021	BUY	$2.01 - $5.55 $413,812 - $1.14 Million	205,877 New	205,877 $914,000

2.24M

Ticker PAVM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 90,999,104
Market Cap $112M
Description
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.